Thomas J. Falk
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2025-05-09
- Valid until
- still holds
- Published
- 2025-05-13
- Recorded by AsOf
- 2026-11-12
- Checked
- 2026-11-12 · its source page states the value and the date
- Confidence
- 0.95
Sources
“On May 9, 2025, AbbVie Inc. (“AbbVie”) expanded the size of its Board of Directors (the “Board”) from fourteen directors to fifteen directors and appointed Thomas J. Falk as a Class III director.”— what the page says, read 2026-11-12
Cite this claim
Plain text
AsOf. "AbbVie board member: Thomas J. Falk", as of 2025-05-09. Claim clm_15E21812936B, https://asof.is/claim/clm_15E21812936B, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm.
APA
AsOf. (2025). AbbVie board member: Thomas J. Falk (as of 2025-05-09) [Record clm_15E21812936B]. Retrieved November 13, 2026, from https://asof.is/claim/clm_15E21812936B (source: https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm)
BibTeX
@misc{asof_clm_15E21812936B,
author = {AsOf},
title = {AbbVie board member: Thomas J. Falk},
year = {2025},
howpublished = {\url{https://asof.is/claim/clm_15E21812936B}},
note = {Claim clm\_15E21812936B, as of 2025-05-09; source: https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm},
urldate = {2026-11-13}
}On the record
/claim/clm_15E21812936B.md/v1/claims/clm_15E21812936Bsubmit a correction